Literature DB >> 22871822

We have a specific duty to maximise the safety of related donors.

Pasquale Iacopino, Attilio Guarini.   

Abstract

Mesh：

Year:  2012        PMID： 22871822      PMCID： PMC3496230          DOI： 10.2450/2012.0042-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  17 in total

1.  Pediatric sibling donors of successful and unsuccessful hematopoietic stem cell transplants (HSCT): a qualitative study of their psychosocial experience.

Authors:  Kendra D MacLeod; Stan F Whitsett; Eric J Mash; Wendy Pelletier
Journal:  J Pediatr Psychol       Date:  2003-06

Review 2.  Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilization of stem cells in normal donors: position of the World Marrow Donor Association.

Authors:  Bronwen E Shaw; Dennis L Confer; William Y Hwang; Derwood H Pamphilon; Michael A Pulsipher
Journal:  Haematologica       Date:  2011-07       Impact factor: 9.941

3.  Back to the OR?

Authors:  Andrea Bacigalupo
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

Review 4.  Can G-CSF cause leukemia in hematopoietic stem cell donors?

Authors:  Belinda R Avalos; Aleksandr Lazaryan; Edward A Copelan
Journal:  Biol Blood Marrow Transplant       Date:  2011-07-13       Impact factor: 5.742

5.  Tumor incidence in related hematopoietic stem cell donors.

Authors:  A Jeger; G Favre; J-M Lutz; M Stern; M Usel; A Rovo; J Rischewski; A Tichelli; A Gratwohl; J Halter
Journal:  Bone Marrow Transplant       Date:  2010-12-20       Impact factor: 5.483

6.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

7.  Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.

Authors:  M Martino; G Console; A Dattola; I Callea; G Messina; T Moscato; E Massara; G Irrera; R Fedele; A Gervasi; G Bresolin; P Iacopino
Journal:  Bone Marrow Transplant       Date:  2009-02-02       Impact factor: 5.483

8.  Severe events in donors after allogeneic hematopoietic stem cell donation.

Authors:  Joerg Halter; Yoshihisa Kodera; Alvaro Urbano Ispizua; Hildegard T Greinix; Norbert Schmitz; Geneviève Favre; Helen Baldomero; Dietger Niederwieser; Jane F Apperley; Alois Gratwohl
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

9.  Management of related donor care: a European survey.

Authors:  S Clare; A Mank; R Stone; M Davies; C Potting; J F Apperley
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

10.  Risk assessment and management for medically complex potential living kidney donors: a few deontological criteria and ethical values.

Authors:  Carlo Petrini
Journal:  J Transplant       Date:  2011-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.